Literature DB >> 28224216

Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients.

Nilton Salles Rosa Neto1, Samuel Katsuyuki Shinjo1, Maurício Levy-Neto1, Rosa Maria Rodrigues Pereira2.   

Abstract

Takayasu arteritis (TA) is an idiopathic chronic inflammatory disease that affects the aorta and its main branches. According to disease involvement, patients may require surgical treatment mainly due ischemic lesions in association with medical therapy. We evaluated the impact of vascular interventions in a cohort of TA patients. Medical records from 146 TA patients were reviewed. Clinical features, medical, and surgical treatment were revised and disease activity was determined by clinical, laboratorial, and imaging parameters. Clinical parameters associated with mortality alongside vascular procedures were evaluated and their impact on mortality in our cohort was estimated. Ninety-four vascular interventions were performed in 61 patients (41.8%). A third of them were of endovascular procedures. The overall mortality was 4.1%, all due to early postoperative complications, which resulted in a rate of surgery-related mortality of 9.8%. All deaths occurred in patients with active disease. Clinical parameters known to be associated with mortality (aneurysm, secondary hypertension, aortic insufficiency, and cerebrovascular accident) were not found related with death. Patients whose disease began before age 20 years had an OR 3.54 of undergoing a vascular surgical intervention. The observed impact of vascular procedures on mortality in patients with Takayasu arteritis, especially during disease activity, supports the notion that such interventions should be performed with caution and preferably during periods of remission.

Entities:  

Keywords:  Epidemiology; Mortality; Takayasu arteritis; Vascular surgery; Vasculitis

Mesh:

Year:  2017        PMID: 28224216     DOI: 10.1007/s00296-017-3656-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  34 in total

1.  Improved prognosis of Takayasu arteritis over the past decade--comprehensive analysis of 106 patients.

Authors:  Hirokazu Ohigashi; Go Haraguchi; Masanori Konishi; Daisuke Tezuka; Tetsuo Kamiishi; Takashi Ishihara; Mitsuaki Isobe
Journal:  Circ J       Date:  2012-02-02       Impact factor: 2.993

2.  Disease progression after initial surgical intervention for Takayasu arteritis.

Authors:  Sung Wan Ham; S Ram Kumar; Vincent L Rowe; Fred A Weaver
Journal:  J Vasc Surg       Date:  2011-08-11       Impact factor: 4.268

3.  Natural history and classification of occlusive thromboaortopathy (Takayasu's disease).

Authors:  K Ishikawa
Journal:  Circulation       Date:  1978-01       Impact factor: 29.690

4.  Angiographic findings of Takayasu arteritis: new classification.

Authors:  A Hata; M Noda; R Moriwaki; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

5.  Visceral Artery Interventions in Takayasu's Arteritis.

Authors:  Sanjiv Sharma; Ashish Gupta
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

6.  Brazilian multicenter study of 71 patients with juvenile-onset Takayasu's arteritis: clinical and angiographic features.

Authors:  Gleice Clemente; Maria Odete Hilário; Claudio Len; Clovis A Silva; Adriana M Sallum; Lúcia M Campos; Silvana Sacchetti; Maria Carolina Dos Santos; Andressa Guariento Alves; Virgínia P Ferriani; Flávio Sztajnbok; Rozana Gasparello; Sheila Knupp Oliveira; Marise Lessa; Blanca Bica; André Cavalcanti; Teresa Robazzi; Marcia Bandeira; Maria Teresa Terreri
Journal:  Rev Bras Reumatol Engl Ed       Date:  2016-02-18

7.  Endovascular management of takayasu arteritis: is it a durable option?

Authors:  Byung-Boong Lee; James Laredo; Richard Neville; J Leonel Villavicencio
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

Review 8.  Treatment and outcomes of large vessel arteritis.

Authors:  Frances A Borg; Bhaskar Dasgupta
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

9.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

10.  Cause of death in Chinese Takayasu arteritis patients.

Authors:  Jing Li; Mengzhu Zhu; Mengtao Li; Wenjie Zheng; Jiuliang Zhao; Xinping Tian; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more
  4 in total

1.  Cardiothoracic surgery and peripheral endovascular intervention in cardiovascular damage from a cohort of orphan rheumatological diseases-epidemiological and survival analysis.

Authors:  Maria Elena Soto; Huitzilihuitl Saucedo-Orozco; Eric Ochoa-Hein; Guering Eid-Lidt; Javier E Anaya-Ayala; Israel Pérez-Torres; Solange Gabriela Koretzky; Pedro A Reyes; Edison Ricardo Espinoza-Saquicela; Ivan Hernandez; Humberto Martinez-Hernandez
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 2.  Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases.

Authors:  Yaxin Zhou; Yuan Feng; Wei Zhang; Hongxia Li; Kui Zhang; Zhenbiao Wu
Journal:  Front Cardiovasc Med       Date:  2021-05-12

Review 3.  Advances in Takayasu arteritis: An Asia Pacific perspective.

Authors:  Debashish Danda; Prathyusha Manikuppam; Xinping Tian; Masayoshi Harigai
Journal:  Front Med (Lausanne)       Date:  2022-08-15

4.  Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis.

Authors:  Ana F Águeda; Sara Monti; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Bhaskar Dasgupta; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.